Report

Multiple Shots on Goal; Initiating with $3.30 Target.

Underlying
Antares Pharma Inc.

Antares Pharma is a pharmaceutical technology company focused on the development and commercialization of self-administered parenteral pharmaceutical products and technologies. The company's injection technology platforms include the VIBEX? and VIBEX? QuickShot? pressure-assisted auto injector systems suitable for branded and generic injectable drugs in unit dose containers as well as disposable multi-dose pen injectors. The company's products include XYOSTED? (testosterone enanthate) injection, which is use for subcutaneous administration of testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone.

Provider
Zacks
Zacks

​Zacks Investment Research is a Chicago based firm with over 30 years of experience in providing institutional and individual investors with the analytical tools and financial information necessary to the success of their investment process.

Other Reports on these Companies
Other Reports from Zacks

ResearchPool Subscriptions

Get the most out of your insights

Get in touch